Biotechnology | COVID-19 | NIH | Vaccine
Emory University Began enrolling older adults in COVID-19 vaccine clinical trial
On Apr. 17, 2020, Emory University announced it had begun enrolling adults over age 55 in the clinical…
-
-
Slower clearance of Coronavirus infection may explain why men fare worse than women
On Apr. 17, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved…
-
CDC | COVID-19 | Life Science History | NIH
The NIH launched a public-private partnership to speed COVID-19 vaccine and treatment options
On Apr. 17, 2020, the NIH and the Foundation for the NIH are bringing together more than a…
-
Penn Medicine launched national component of global registry to track exposures and outcomes among providers who intubate
On Apr. 16, 2020, a team at the Perelman School of Medicine at the University of Pennsylvania launched…
-
COVID-19 | Infectious Disease | NIH | Vaccine
IVI, INOVIO, and KNIH partner with CEPI in phase 1/2 clinical trial of INOVIO’s COVID-19 DNA vaccine in South Korea
On Apr. 16, 2020, the International Vaccine Institute (IVI) announced that the Coalition for Epidemic Preparedness Innovations (CEPI)…
-
Mammoth Biosciences announced peer-reviewed validation of its rapid, CRISPR-based COVID-19 diagnostic
On Apr. 16, 2020, Mammoth Biosciences announced the publication of a study demonstrating the power of its platform…
-
COVID-19 | FDA | Infectious Disease | Vaccine
Dynavax and Sinovac announced collaboration to develop a Coronavirus (COVID-19) vaccine
On Apr. 16, 2020, Dynavax and Sinovac Biotech, a leading provider of biopharmaceutical products in China, announced that…
-
Mayo Clinic prepared to commenced phase II FDA clinical trial for treatment of COVID-19 with Vicromax
On Apr. 16, 2020, BioSig Technologies announced that its subsidiary ViralClear Pharmaceuticals, had updated its clinical development program…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
Biogen, Broad Institute of MIT and Harvard, Partners HealthCare launched consortium to build and share a COVID-19 Biobank
On Apr. 16, 2020, Biogen, Broad Institute of MIT and Harvard, and Partners HealthCare announced a consortium that…
-
Pulmatrix and Sensory Cloud announced partnership to develop and commercialize nasal prophylactic and anticontagion product for COVID-19
On Apr. 16, 2020, Pulmatrix announced a collaboration and license agreement with Sensory Cloud. Under the terms of…
-
Moderna announced BARDA award for up to $483 million to accelerate development of mRNA vaccine (mRNA-1273) against novel Coronavirus
On Apr. 16, 2020, the U.S. government announced it will fund development of an experimental coronavirus vaccine from…
-
CHF Solutions announced 300% increase in utilization of Aquadex Therapy in NYC hospitals, the epicenter of COVID-19
On Apr. 16, 2020, CHF Solutions announced increased utilization of its Aquadex therapy in patients affected by COVID-19….
-
Soligenix announced exclusive licensing agreement for novel vaccine adjuvant from BTG Specialty Pharmaceuticals
On Apr. 16, 2020, Soligenix announced it has executed an agreement for the exclusive worldwide license of CoVaccine…
-
Atossa Therapeutics launched COVID-19 HOPE drug development program
On Apr. 16, 2020, Atossa Therapeutics announced a new drug development program called COVID-19 HOPE. The program used…
-
Vanda Pharma and Northwell Health conduct ODYSSEY trial in patients with severe COVID-19 pneumonia
On Apr. 15, 2020, Vanda Pharma and Northwell Health’s research arm, The Feinstein Institutes for Medical Research, announced…
-
Chembio Diagnostics received Emergency Use Authorization for DPP COVID-19 s for IgG and IgM antibodies
On Apr. 15, 2020, Chembio Diagnostics announced receipt of FDA Emergency Use Authorization (EUA) for its DPP COVID-19…
-
Singapore researchers use NanoString’s nCounter to rapidly profile response of immune system to SARS-CoV-2 virus
On Apr. 15, 2020, NanoString Technologies announced the first publication utilizing the nCounter platform and its leading gene…
-
U of A virology lab finds drug originally meant for Ebola effective against key enzyme of coronavirus that causes COVID-19
On Apr. 15, 2020, scientists at the University of Alberta have shown that the drug remdesivir is highly…
-
Abbott launched third COVID-19 test, a laboratory-based antibody blood test
On Apr. 15, 2020, Abbott announced the launch of its third COVID-19 test, a lab-based serology blood test…
-
HALIX entered collaboration with University of Oxford for GMP manufacturing of a COVID-19 vaccine
On Apr. 15, 2020, HALIX announced it had joined a consortium of partners under the guidance of the…
-
Ventilator Manufacturers Group established the Ventilator Training Alliance to help frontline medical workers during pandemic
On Apr. 15, 2020, Getinge announced support of the Ventilator Manufacturers Group to form Ventilator Training Alliance (VTA)…
-
NIH study validated decontamination methods for re-use of N95 respirators
On Apr. 15, 2020, N95 respirators can be decontaminated effectively and maintain functional integrity for up to three…
-
Fujifilm accelerated production of its influenza antiviral drug ‘Avigan tablet’ for COVID-19
On Apr. 15, 2020, FUJIFILM announced that it had expanded its manufacturing capacity at FUJIFILM Toyama Chemical Co.,…
-
Biotechnology | COVID-19 | Diagnostics | Medicine | Therapeutics | Vaccine
The Bill & Melinda Gates Foundation expands its commitment to global COVID-19 response
On Apr. 15, 2020, the Bill & Melinda Gates Foundation announced an expansion of its funding for the…
-
FDA authorized first-of-its-kind low-cost ventilator developed by University of Minnesota
On Apr. 15, 2020, the U.S. Food and Drug Administration (FDA) authorized the production and use of a…
-
Orthoﾒs total antibody test for COVID-19 received Emergency Use Authorization from FDA
On Apr. 15, 2020, the FDA announced it granted Emergency Use Authorization to Ortho Clinical Diagnosticsﾒ total antibody…
-
Todos Medical received medical importer status with U.S. FDA
On Apr. 15, 2020, Todos Medical announced the U.S. Food and Drug Administration (FDA) has accepted Todos Medical’s application…
-
Philips detailed plans to increase its hospital ventilator production to 4,000 units/week by Q3 2020
On Apr. 14, 2020, Royal Philips announced that it planed to double the production of its hospital ventilators…
-
Philips joined forces with Flex and Jabil to speed the production of hospital ventilators
On Apr. 14, 2020, Philips announced that it had joined forces with manufacturing partners Flex and Jabil to…
-
AstraZeneca initiated CALAVI clinical trial with Calquence against COVID-19
On Apr. 14, 2020, AstraZeneca initiated a randomised, global clinical trial to assess the potential of Calquence (acalabrutinib)…
